Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K220729
    Date Cleared
    2022-06-09

    (87 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Luminance Medical Ventures, Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Luminance RED Acne Device is intended to enit energy in the spectrum, and is specifically indicated to treat mild to moderate acne.

    Device Description

    The Luminance RED Acne Device is a lightweight, handheld device that consists of a body handle and treatment head. The body handle contains 2 LEDs that emit visible blue light (415 nm +/- 10 nm) or visible red light (660 nm +/- 10 nm) through the treatment head to help reduce the appearance of mild to moderate acne. The body consists of a plastic shell which includes a button to turn the device on/off, a button for red visible light, a button for blue visible light, and a digital countdown timer. The Luminance RED Acne Device is powered by a lithium-ion battery.

    AI/ML Overview

    The provided documents describe the Luminance RED Acne Device, a handheld LED device intended to treat mild to moderate acne. However, the documents do not contain information about acceptance criteria or a study proving the device meets acceptance criteria.

    The submission is a 510(k) premarket notification, which establishes substantial equivalence to legally marketed predicate devices, rather than proving efficacy through clinical trials with defined acceptance criteria.

    The 510(k) summary (Section 5) explicitly states:

    • "No clinical testing was conducted as part of this 510(k) submission" (Page 8, Section 5.13).
    • The conclusion is based on "nonclinical tests" demonstrating the device is "as safe, as effective, and performs as well as or better than the legally marketed predicate device" (Page 8, Section 5.14).

    Therefore, I cannot provide the requested information regarding acceptance criteria and a study proving the device meets those criteria because it is not present in the provided text.

    The closest information available is the comparison to predicate devices for substantial equivalence, which includes characteristics like:

    • Indications for Use: Treat mild to moderate acne (same as predicates).
    • Energy Type: LED (same as predicates).
    • Wavelength: 415 nm (+/-10 nm) and 660 nm (+/-10 nm) (similar to predicates).
    • Dose Rate: 4.5 Joules of each wavelength (red and blue), 50 mW/cm² for each (similar to predicates).
    • Treatment Regimen: 90 seconds of blue light, then 90 seconds of red light, 2 times per day (similar to predicates).
    • Safety Testing: Adherence to IEC standards (IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, IEC 60601-2-57, IEC 62471).
    • Usability Testing: Yes, per guidance and IEC 62366.
    • Biocompatibility Testing: Cytotoxicity, Irritation, Sensitization.

    These are design and testing parameters to demonstrate substantial equivalence, not performance acceptance criteria from a clinical study.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1